Matinas Biopharma Holdings Inc (MTNB) Live Share Price, Invest From India

Matinas Biopharma Holdings Inc Stock Performance

as on March 25, 2026 at 6:59 am IST

Day's Low
Day's High
$0.60
Day's Price Range
$0.66
$0.64
6.25%
Downside
3.13%
Upside
52 Week's Low
52 Week's High
$0.47
52-Week Price Range
$3.09
$0.64
25.81%
Downside
382.81%
Upside

Matinas Biopharma Holdings Inc share price movements today

Previous Close: $0.64
Open: $0.66
Volume: 518.4K
Day's Low - High: $0.60 - $0.66
52 Week Low - High: $0.47 - $3.09

Matinas Biopharma Holdings Inc Historical Returns

1 Month Return: + 6.21 %
3 Month Return: -7.49 %
1 Year Return: + 14.2 %
3 Year Return: -96.79 %
5 Year Return: -98.86 %

Matinas Biopharma Holdings Inc Stock Fundamentals & Key Indicators

Check Matinas Biopharma Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.1M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.02

Industry PE ratio

PEG Ratio

EBITDA

-9.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-151.68%

Matinas Biopharma Holdings Inc Stock Valuation

Track how Matinas Biopharma Holdings Inc P/E has moved over time to understand its valuation trends.

Matinas Biopharma Holdings Inc in the last 5 years

Overview
Trends

Lowest (-111.63x)

September 30, 2023

Industry (0.00x)

March 25, 2026

Today (-1.02x)

March 25, 2026

Highest (-0.21x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.02x

Matinas Biopharma Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Matinas Biopharma Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Matinas Biopharma Holdings Inc	BUY	$4.1M	-98.86%	-1.02	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.4B	126.75%	133.41	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.3B	112.49%	29.68	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.5B	58.91%	17.67	31.41%

Stock Returns calculator for Matinas Biopharma Holdings Inc Stock including INR - Dollar returns

The Matinas Biopharma Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Matinas Biopharma Holdings Inc investment value today

Current value as on today

₹1,23,826

Returns

₹23,826

(+23.83%)

Returns from Matinas Biopharma Holdings Inc Stock

₹14,286 (+14.29%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Matinas Biopharma Holdings Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Matinas Biopharma Holdings Inc. Average target price of $30

Matinas Biopharma Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Matinas Biopharma Holdings Inc.

What analysts predicted

97.87%UPSIDE

Target Price

$30

Current Price

$0.64

Analyzed by

9 Analysts

Target

$30.00

Matinas Biopharma Holdings Inc target price $30, a slight upside of 97.87% compared to current price of $0.64. According to 9 analysts rating.

Matinas Biopharma Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Matinas Biopharma Holdings Inc Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 23, 2026 to March 25, 2026

Change:-54% versus previous 30 day period

Matinas Biopharma Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	-1	-	-	-	-	0	-	-
Gross Profit	-3	-3	-3	0	-3	-2	-	0	0	-
Operating Income	-6	-6	-5	-5	-5	-4	-4	-1	-1	-1
EBITDA	-6	-6	-5	-5	-5	-4	-	-1	-1	-2
Interest Expense	-	-	0	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-6	-5	-5	-5	-4	-8	-1	-5	-2
Income Tax Expense	0	0	0	0	-	-	-	0	-	-
Net Income	-6	-6	-5	-5	-5	-4	-8	-1	-5	-2
Net Profit Margin	0.00%	0.00%	484.85%	0.00%	0.00%	0.00%	0.00%	-172.14%	0.00%	0.00%

Matinas Biopharma Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	0	0	0	0	0	3	1	-
Gross Profit	-5	0	-8	-6	-11	-14	-14	-13	1	0
Operating Income	-9	-8	-16	-14	-18	-24	-24	-24	-23	-24
EBITDA	-9	-8	-16	-14	-18	-23	-24	-24	-22	-19
Interest Expense	-	-	-	-	-	-	1	3	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-9	-7	-15	-14	-17	-22	-23	-20	-22	-24
Income Tax Expense	0	0	0	0	-1	-1	-2	-7	0	0
Net Income	-9	-7	-15	-14	-17	-22	-23	-20	-22	-24
Net Profit Margin	-4697.01%	0.00%	-10345.91%	-11760.39%	-19343.35%	-14176.98%	-70554.55%	-658.63%	-2093.25%	0.00%

Matinas Biopharma Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-6	-5	-5	-5	-4	-8	-1	-5	-1
Operating Cash Flow	-4	-4	-5	-3	-3	-3	-2	-2	-1
Investing Cash Flow	1	2	2	-2	9	-	0	-	0
Financing Cash Flow	0	0	0	9	0	0	1	1	0
Change in Cash	-3	-1	-3	3	6	-3	0	0	-1

Matinas Biopharma Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-15	-14	-17	-22	-23	-20	-22	-24
Operating Cash Flow	-6	-11	-10	-14	-17	-15	-19	-15	-15
Investing Cash Flow	0	0	0	-6	-40	16	4	13	9
Financing Cash Flow	6	15	15	29	48	6	0	0	9
Change in Cash	0	3	5	9	-9	8	-14	-2	2

Insights on Matinas Biopharma Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -1.09M → 962.0K (in $), with an average increase of 213.9% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -5.24M → -2.15M (in $), with an average increase of 144.0% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, MTNB stock has moved up by 7.6%
NO EFFECT
Against Peers
In the last 3 years, Matinas Biopharma Holdings Inc has experienced a drawdown of -96.8%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 86.6%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 16.1% return, outperforming this stock by 1.9%

About Matinas Biopharma Holdings Inc

matinas biopharma (nyse mkt: mtnb) is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications. the company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. the company's lead drug candidate mat2203, currently in phase 2, is an orally-administered, encochleated formulation of amphotericin b (a broad spectrum fungicidal agent). the company has an open investigational new drug (ind) application for mat2501, currently in phase 1, which is an orally-administered, encochleated formulation of amikacin (a broad spectrum aminoglycoside antibiotic agent) for acute bacterial infections, including non-tuberculous mycobacterium (ntm) and multi-drug resistant gram negative bacterial infections. the company's lead anti-infective product candidates, mat2203 and mat2501, position matinas biopharma to bec

Organisation	Matinas Biopharma Holdings Inc
Headquarters	1545 Route 206 South, Bedminster, NJ, United States, 07921
Industry	Health Technology
CEO	Mr. Jerome D. Jabbour J.D.
E-voting on shares	Click here to vote

Key Management of Matinas Biopharma Holdings Inc

Name	Title
Mr. Jerome D. Jabbour J.D.	Co-Founder, Chairman, CEO, President & Interim CFO

FAQs

What is Matinas Biopharma Holdings Inc share price today?

Matinas Biopharma Holdings Inc share price today is $0.64 as on March 25, 2026 at 1:29 am IST at the close of the market. Matinas Biopharma Holdings Inc share today touched a day high of $0.66 and a low of $0.6.

What is the 52 week high and 52 week low for Matinas Biopharma Holdings Inc share?

Matinas Biopharma Holdings Inc share touched a 52 week high of $3.09 on August 15, 2025 and a 52 week low of $0.47 on April 8, 2025. Matinas Biopharma Holdings Inc stock price today i.e. March 25, 2026 at 1:29 am IST is closed at $0.64,which is 79.29% down from its 52 week high and 34.79% up from its 52 week low.

What is Matinas Biopharma Holdings Inc's market capitalisation today?

Matinas Biopharma Holdings Inc market capitalisation is $0.00T as on March 25, 2026 at 1:29 am IST.

How to invest in Matinas Biopharma Holdings Inc Stock (MTNB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Matinas Biopharma Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Matinas Biopharma Holdings Inc Shares that will get you 2.3438 shares as per Matinas Biopharma Holdings Inc share price of $0.64 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Matinas Biopharma Holdings Inc Stock (MTNB) from India?

Indian investors can start investing in Matinas Biopharma Holdings Inc (MTNB) shares with as little as ₹93.734 or $1 (as of March 25, 2026 at 7:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Matinas Biopharma Holdings Inc stock (as per the Rupee-Dollar exchange rate as on March 25, 2026 at 7:39 am IST). Based on Matinas Biopharma Holdings Inc share’s latest price of $0.64 as on March 25, 2026 at 1:29 am IST, you will get 15.6250 shares of Matinas Biopharma Holdings Inc. Learn more about fractional shares .

What are the returns that Matinas Biopharma Holdings Inc has given to Indian investors in the last 5 years?

Matinas Biopharma Holdings Inc stock has given -98.86% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?